Institute of Biomedicine

Contact Details

Persons

  

  

  

1 of 31

  

  

  

---

• Aaltonen, Virpi
• Aatsinki, Milla
• Abbas, Hyder
• Abdelkawy, Yara
• Abe, Oluwatosin
• Abid, Tazrian
• Abouguendia, Hatem
• Abuasaker, Baraa
• Adamsson, Annika
• Afshan, Syeda
• Ahmedani, Ammar
• Ahmed, Nisar
• Ahramo, Kaisa
• Airaksinen, Jenni
• Åkerfelt, Malin
• Akram, Sadia
• Alanne, Erika
• Ali, Aliaa
• Alinikula, Jukka
• Alipour, Maedeh

Publications

  

  

  

85 of 521

  

  

  

---

• Class II HLA genotype association with FPIR reflects the islet autoantibody status  (2016)
• Clear Cell Neoplasms of Salivary Glands: A Diagnostic Challenge  (2022)
• Clear cell squamous cell carcinoma of the tongue exhibits characteristics as an undifferentiated squamous cell carcinoma  (2022)
• Clever-1 contributes to lymphocyte entry into the spleen via the red pulp  (2019)
• Clever-1 inhibition in human cancer: consequences and control of bexmarilimab-induced macrophage activation  (2026)
• CLEVER-1 targeting antibody, bexmarilimab, supports HLA-DR expression and alters ex vivo responsiveness to azacitidine and venetoclax in myeloid malignancies  (2025)
• Clinical and genetic characteristics and natural history of Finnish families with familial exudative vitreoretinopathy due to pathogenic FZD4 variants  (2025)
• Clinical and Genetic Characteristics of Finnish Patients with Autosomal Recessive and Dominant Non-Syndromic Hearing Loss Due to Pathogenic TMC1 Variants  (2022)
• Clinical and microbiological characterization of Aerococcus urinae bacteraemias at Helsinki metropolitan area, Finland  (2022)
• Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic The past and the near future  (2021)